Candriam S.C.A. Gossamer Bio, Inc. Transaction History
Candriam S.C.A.
- $16.9 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
112Shares Held
168MCall Options Held
450KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$19.2 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$14.1 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$12.5 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$9.74 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$8.54 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $99.6M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...